Co-Authors
This is a "connection" page, showing publications co-authored by Rongchang Chen and Nanshan Zhong.
Connection Strength
3.153
-
Strategies for the prevention and management of coronavirus disease 2019. Eur Respir J. 2020 04; 55(4).
Score: 0.219
-
Health Perception and Behaviors in Adults With Bronchiectasis. Respir Care. 2019 Apr; 64(4):462-472.
Score: 0.200
-
Sputum purulence-associated microbial community compositions in adults with bronchiectasis. J Thorac Dis. 2018 Sep; 10(9):5508-5514.
Score: 0.196
-
Altered community compositions of Proteobacteria in adults with bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2018; 13:2173-2182.
Score: 0.194
-
Next-generation sequencing for identifying genetic mutations in adults with bronchiectasis. J Thorac Dis. 2018 May; 10(5):2618-2630.
Score: 0.191
-
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis. Eur Respir J. 2018 01; 51(1).
Score: 0.187
-
RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells. Mol Carcinog. 2017 Nov; 56(11):2391-2399.
Score: 0.183
-
Residual volume/total lung capacity ratio confers limited additive significance to lung clearance index for assessment of adults with bronchiectasis. PLoS One. 2017; 12(9):e0183779.
Score: 0.183
-
Additional important research priorities for bronchiectasis in China. Eur Respir J. 2017 01; 49(1).
Score: 0.175
-
Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015. Emerg Infect Dis. 2015 Dec; 21(12):2278-80.
Score: 0.162
-
The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study. Chest. 2015 Jun; 147(6):1635-1643.
Score: 0.156
-
Effect of airway Pseudomonas aeruginosa isolation and infection on steady-state bronchiectasis in Guangzhou, China. J Thorac Dis. 2015 Apr; 7(4):625-36.
Score: 0.155
-
Six-minute walk test in Chinese adults with clinically stable bronchiectasis: association with clinical indices and determinants. Curr Med Res Opin. 2015 Apr; 31(4):843-52.
Score: 0.154
-
Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006 Jan; 11(1):49-53.
Score: 0.081
-
[Changes in pulmonary function in severe acute respiratory syndrome patients during convalescent period]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Jun; 17(6):329-31.
Score: 0.078
-
Evaluation by indirect immunofluorescent assay and enzyme linked immunosorbent assay of the dynamic changes of serum antibody responses against severe acute respiratory syndrome coronavirus. Chin Med J (Engl). 2005 Mar 20; 118(6):446-50.
Score: 0.077
-
SARS: ventilatory and intensive care. Respirology. 2003 Nov; 8 Suppl:S31-5.
Score: 0.070
-
Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020 10 01; 130(10):5235-5244.
Score: 0.057
-
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 08 06; 182(3):734-743.e5.
Score: 0.055
-
Veno-venous extracorporeal membrane oxygenation for patient with a history of open cholecystectomy and acute respiratory distress syndrome caused by coinfection of avian influenza A (H7N9) and Epstein-Barr virus. Chin Med J (Engl). 2019 Jun 05; 132(11):1363-1364.
Score: 0.052
-
Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases. Clin Lung Cancer. 2019 05; 20(3):e329-e337.
Score: 0.050
-
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA. Int J Chron Obstruct Pulmon Dis. 2018; 13:2969-2984.
Score: 0.049
-
Asthma Phenotypes Defined From Parameters Obtained During Recovery From a Hospital-Treated Exacerbation. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):1960-1967.
Score: 0.047
-
Inhaled medication therapy for bronchiectasis: status quo and the next frontier. Expert Opin Investig Drugs. 2018 03; 27(3):211-218.
Score: 0.047
-
Pulmonary Capillary Hemangiomatosis without Pulmonary Hypertension: An Early Stage of Disease? Chin Med J (Engl). 2018 Jan 20; 131(2):245-246.
Score: 0.047
-
Role of BAFF in pulmonary autoantibody responses induced by chronic cigarette smoke exposure in mice. Physiol Rep. 2016 12; 4(24).
Score: 0.043
-
Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism. Clin Chim Acta. 2016 Aug 01; 459:25-29.
Score: 0.042